Apixaban and Spinal cord compression - a phase IV clinical study of FDA data

Summary:

Spinal cord compression is reported as a side effect among people who take Apixaban (apixaban), especially for people who are female, 60+ old, have been taking the drug for 2 - 5 years also take Fentanyl, and have Atrial fibrillation/flutter.

The phase IV clinical study analyzes which people have Spinal cord compression when taking Apixaban. It is created by eHealthMe based on reports of 60,044 people who have side effects when taking Apixaban from the FDA, and is updated regularly.

What is Apixaban?

Apixaban has active ingredients of apixaban. It is often used in blood clots. eHealthMe is studying from 60,351 Apixaban users. Check the latest studies of Apixaban.

What is Spinal cord compression?

Spinal cord compression is found to be associated with 616 drugs and 597 conditions by eHealthMe. Check the latest studies of Spinal cord compression.

On Jul, 20, 2026

60,044 people reported to have side effects when taking Apixaban.
Among them, 21 people (0.03%) have Spinal cord compression.

Could Apixaban cause Spinal cord compression?

Among these 21 people:

How long have people been on Apixaban when they have Spinal cord compression? *

What is the gender of people who have Spinal cord compression when taking Apixaban? *

female: 66.67 %
male: 33.33 %

What is the age of people who have Spinal cord compression when taking Apixaban? *

What are other drugs people take besides Apixaban? *

What are other side effects people have besides Spinal cord compression? *

Spinal Epidural Haematoma (blood clot into the epidural space in the spine): 6 people, 28.57%
Cerebral Haemorrhage (bleeding within the brain): 6 people, 28.57%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 5 people, 23.81%
Monoplegia (a paralysis of a single limb): 5 people, 23.81%
Anticoagulation Drug Level Above Therapeutic: 5 people, 23.81%
Metastases To Liver (cancer spreads to liver): 2 people, 9.52%
Diarrhea: 2 people, 9.52%
Haemoglobin Decreased: 2 people, 9.52%
Pain: 2 people, 9.52%
Spinal Cord Haemorrhage (bleeding in spinal cord): 2 people, 9.52%

What are the existing conditions these people have? *

Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 8 people, 38.10%
General Anaesthesia: 6 people, 28.57%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 3 people, 14.29%
Pulmonary Embolism (blockage of the main artery of the lung): 3 people, 14.29%
Multiple Myeloma (cancer of the plasma cells): 3 people, 14.29%
Lung Cancer - Non-Small Cell (lung cancer): 3 people, 14.29%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 4.76%
Breast Cancer Metastatic: 1 person, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Apixaban and have Spinal cord compression?

- Check whether Spinal cord compression is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Apixaban:

Apixaban (60,351 reports)

Browse all side effects of Apixaban:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Spinal cord compression:

Spinal cord compression (616 drugs)

Browse all the conditions that are associated with Spinal cord compression:

Spinal cord compression (597 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on apixaban (the active ingredients of Apixaban) and Apixaban (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.